<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27703453</article-id>
<article-id pub-id-type="pmc">5028383</article-id>
<article-id pub-id-type="doi">10.3389/fmicb.2016.01479</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fang</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/377287/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Shaoguo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meng</surname>
<given-names>Fanjing</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xiaolei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Hua</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Tingtao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/364560/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Neurology, The First Affiliated Hospital of Nanchang University</institution>
<country>Nanchang, China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Translational Medicine, Nanchang University</institution>
<country>Nanchang, China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>State Key Laboratory of Food Science and Technology, Nanchang University</institution>
<country>Nanchang, China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <italic>George Tsiamis, University of Patras, Greece</italic></p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <italic>Spyridon Ntougias, Democritus University of Thrace, Greece; Shengguo Zhao, Chinese Academy of Agricultural Sciences, China</italic></p>
</fn>
<corresp id="fn001">*Correspondence: <italic>Tingtao Chen, <email xlink:type="simple">chentingtao1984@163.com</email></italic></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Systems Microbiology, a section of the journal Frontiers in Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>1479</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Fang, Wang, Yang, Meng, Wang, Wei and Chen.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Fang, Wang, Yang, Meng, Wang, Wei and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>More and more evidences indicate that diseases of the central nervous system have been seriously affected by fecal microbes. However, little work is done to explore interaction between amyotrophic lateral sclerosis (ALS) and fecal microbes. In the present study, high-throughput sequencing method was used to compare the intestinal microbial diversity of healthy people and ALS patients. The principal coordinate analysis, Venn and unweighted pair-group method using arithmetic averages (UPGMA) showed an obvious microbial changes between healthy people (group H) and ALS patients (group A), and the average ratios of <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Anaerostipes</italic>, <italic>Prevotella</italic>, <italic>Escherichia</italic>, and <italic>Lachnospira</italic> at genus level between ALS patients and healthy people were 0.78, 2.18, 3.41, 0.35, 0.79, and 13.07. Furthermore, the decreased Firmicutes/Bacteroidetes ratio at phylum level using LEfSE (LDA &gt; 4.0), together with the significant increased genus <italic>Dorea</italic> (harmful microorganisms) and significant reduced genus <italic>Oscillibacter</italic>, <italic>Anaerostipes</italic>, <italic>Lachnospiraceae</italic> (beneficial microorganisms) in ALS patients, indicated that the imbalance in intestinal microflora constitution had a strong association with the pathogenesis of ALS.</p>
</abstract>
<kwd-group>
<kwd>high-throughput sequencing</kwd>
<kwd>amyotrophic lateral sclerosis (ALS)</kwd>
<kwd>microbial diversity</kwd>
<kwd>principal coordinate analysis (PCoA)</kwd>
<kwd>central nervous system (CNS)</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="40"></ref-count>
<page-count count="7"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Amyotrophic lateral sclerosis (ALS) belongs to idiopathic, fatal neurodegenerative disease of the human motor system (<xref ref-type="bibr" rid="B12">Gordon, 2011</xref>), characterized by the loss of neurons at all levels of the motor system—from the cortex to the anterior horn of the spinal cord (<xref ref-type="bibr" rid="B17">Kiernan et al., 2011</xref>). The scientific and clinical interest in ALS is growing since the 1990s, and survival in ALS is now understood to be dependent on clinical presentation (phenotype), rate of disease progression, early presence of respiratory failure, and the nutritional status of patients (<xref ref-type="bibr" rid="B17">Kiernan et al., 2011</xref>; <xref ref-type="bibr" rid="B11">Fang, 2015</xref>). Unfortunately, less than 50% of patients can survive within 3 years of onset (<xref ref-type="bibr" rid="B12">Gordon, 2011</xref>; <xref ref-type="bibr" rid="B17">Kiernan et al., 2011</xref>; <xref ref-type="bibr" rid="B11">Fang, 2015</xref>).</p>
<p>The human gastrointestinal tract is home to bacterial communities, and the microbes have profound implications on human metabolism, immunity and the gut-brain axis (<xref ref-type="bibr" rid="B9">Derrien and van Hylckama Vlieg, 2015</xref>; <xref ref-type="bibr" rid="B32">Sivan et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Yu et al., 2015</xref>; <xref ref-type="bibr" rid="B40">Zhernakova et al., 2016</xref>), and numerous studies have highlighted interactions between the central nervous system (CNS) and the gastrointestinal system (<xref ref-type="bibr" rid="B10">Erny et al., 2015</xref>; <xref ref-type="bibr" rid="B34">Wang et al., 2016</xref>). The brain may modulate peripheral gut functions to modify the gastrointestinal composition via releasing gut factors (hormones, neurotransmitters, immune factors), and the gut microbes, on the other hand, interact with the CNS by releasing of neurotransmitters, e.g., nitric oxide (NO, a major neurotransmitter in the brain) and g-aminobutyric acid (GABA, neurotransmitter produced <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic>) (<xref ref-type="bibr" rid="B26">Rhee et al., 2009</xref>; <xref ref-type="bibr" rid="B2">Barrett, 2014</xref>; <xref ref-type="bibr" rid="B35">Williams et al., 2014</xref>; <xref ref-type="bibr" rid="B5">Cani and Knauf, 2016</xref>). Short-chain fatty acids (SCFAs), the specific metabolites generated by gut bacteria, can cross the blood–brain barrier and its levels in the feces could be correlated negatively or positively (<xref ref-type="bibr" rid="B30">Serre et al., 2015</xref>) with autism spectrum disorders (ASD) (<xref ref-type="bibr" rid="B1">Adams et al., 2011</xref>). Moreover, researchers found that lipopolysaccharide (LPS), a constituent of Gram-negative bacteria markedly affected vagal afferent neuron function, with reduced vagal afferent leptin signaling (<xref ref-type="bibr" rid="B30">Serre et al., 2015</xref>).</p>
<p>Intestinal barrier dysfunction may promote the passage of toxins in the intestinal lumen into the blood, and the innate immune response and increased circulating LPS play pivotal roles in the pathogenesis of ALS (<xref ref-type="bibr" rid="B25">Nguyen et al., 2004</xref>; <xref ref-type="bibr" rid="B39">Zhang et al., 2009</xref>). Furthermore, reduced tight junction proteins in the lumbar spinal cord, as well as the disruption of tissue barriers (the blood–spinal cord barrier and the blood–brain barrier) were identified both in ALS patients and animal models (<xref ref-type="bibr" rid="B18">Longstreth et al., 2005</xref>). However, the interaction of the gut microbiota with the ALS has not been investigated.</p>
<p>In the past, only a small fraction of all bacteria have been isolated and characterized severely limited by available technology and the shortage of reference genomes (<xref ref-type="bibr" rid="B38">Yue-Xin et al., 2003</xref>; <xref ref-type="bibr" rid="B31">Shokralla et al., 2012</xref>), and recent technological advances in next generation sequencing technology has enabled elucidation of the pleiotropic effects of microorganisms on the human host (<xref ref-type="bibr" rid="B9">Derrien and van Hylckama Vlieg, 2015</xref>; <xref ref-type="bibr" rid="B32">Sivan et al., 2015</xref>; <xref ref-type="bibr" rid="B37">Yu et al., 2015</xref>; <xref ref-type="bibr" rid="B40">Zhernakova et al., 2016</xref>). In the present study, the high-throughput sequencing analyses were used to assess the interaction of the gut microbiota and the ALS, which proves basic data for the prevention and treatment of ALS.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Ethical Statement and Patients</title>
<p>The study was approved by the Ethical Committee of The First Affiliated Hospital of Nanchang University, all participants provided written informed consent and all the methods were carried out in accordance with the approved guidelines.</p>
<p>Six consecutive patients with ALS (according to the revised El Escorial criteria) were recruited (<xref ref-type="bibr" rid="B3">Brooks et al., 2000</xref>) at The First Affiliated Hospital of Nanchang University between 07/2015 and 05/2016, and patients who were unable to communicate, either verbally or by writing, were excluded. None had additional neurological disease or previous mental illness. Respiratory function measured by forced vital capacity (FVC) was above 70% and there was no evidence of nocturnal hypoventilation (Supplementary Table <xref ref-type="supplementary-material" rid="SM1"> S1</xref>). Five healthy people without ALS were recruited as control. All people with random diets donated their first fecal motion of the day for only one time and the samples were stored at -70°C.</p>
</sec>
<sec>
<title>Extraction of Genomic DNA and High-Throughput Sequencing</title>
<p>Genomic DNA from each sample was extracted using a TIANamp Genomic DNA kit (TIANGEN) combined with bead beating as previously published (<xref ref-type="bibr" rid="B37">Yu et al., 2015</xref>). Then the Genomic DNA was sent to the one of the most famous high-throughput sequencing company for high-throughput sequencing and analysis.</p>
<p>The extracted genomic DNA was used as the template to amplify the V3–V4 region of 16S rRNA genes using the primer pair 338F/806R with the barcode. PCR reactions, pyrosequencing of the PCR amplicons and quality control of raw data were performed as described previously with minor modification (<xref ref-type="bibr" rid="B36">Xu et al., 2015</xref>).</p>
</sec>
<sec>
<title>Bioinformatics and Multivariate Statistics</title>
<p>Low-quality sequences were eliminated from analysis based on the following criteria: (a) raw reads shorter than 400 bp; (b) a sequence producing more than eight homopolymers; (c) &gt;2 mismatches in the primers, or, (d) one or more mismatches in the barcode. Pyrosequenced amplicons were removed using the PyroNoise algorithm in Mothur (<xref ref-type="bibr" rid="B29">Schloss et al., 2009</xref>). Bioinformatic analysis was implemented using the Quantitative Insights Into Microbial Ecology (QIIME) platform (<xref ref-type="bibr" rid="B6">Caporaso et al., 2010</xref>). Briefly, 16S rRNA operational taxonomic units (OTUs) were clustered using an open-reference OTU picking protocol based on 97% nucleotide similarity with the UCLUST algorithm (<xref ref-type="bibr" rid="B8">Davenport et al., 2014</xref>). ChimeraSlayer was employed to remove chimeric sequences (<xref ref-type="bibr" rid="B14">Haas et al., 2011</xref>). The relative abundance of each OTU was determined as a proportion of the sum of sequences for each sample. Taxonomic relative abundance profiles (such as, at the phylum, class, order, family, and genus levels) were generated based on OTU annotation. The microbial community structure (i.e., species richness, evenness and between-sample diversity) of bacterial samples was estimated by biodiversity. Shannon index, phylogenetic diversity, Chao1 index, and the observed number of species were used to evaluate alpha diversity, and the weighted and unweighted UniFrac distances were used to evaluate beta diversity.</p>
<p>All of these indices (alpha and beta diversity) were calculated by the QIIME pipeline.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Statistical analysis was implemented using the R platform. Principal coordinate analysis (PCoA) was performed using the “ape” package based on the UniFrac distances between samples. The difference among groups was further assessed using a non-parametric test via Metastats software<sup><xref ref-type="fn" rid="fn01">1</xref></sup> as described previously (<xref ref-type="bibr" rid="B19">Lu et al., 2014</xref>), and statistical significance was set at <italic>p</italic> &lt; 0.05 for correction of multiple comparisons.</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Sequencing Coverage</title>
<p>To compare the fecal microbes of healthy people (group H) and ALS patients (group A), 16S rRNA amplicon sequencing analysis was used to sequence the V3–V4 hypervariable region, and the sequencing data was filtered to get the valid data, and all the effective tags of all samples were clustered and those sequences with over 97% similarity were considered as one OTU. In total, 802695.96 filtered clean tags (72972.36 tags/sample) and 2540 OTUs were obtained from all the samples with an average of 230.91 OTUs per group (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Chao1 index had almost got saturated and the rarefaction curve of every sample could enter the plateau phase (Supplementary Figure <xref ref-type="supplementary-material" rid="SM1"> S1</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Number of raw tags, clean tags, average bp, OTUs, and actual bacterial composition in groups A and H by high-throughput sequencing.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Sample ID</th>
<th align="center" colspan="1" rowspan="1" valign="top">Raw Tags</th>
<th align="center" colspan="1" rowspan="1" valign="top">Clean Tags</th>
<th align="center" colspan="1" rowspan="1" valign="top">AvgLen (bp)</th>
<th align="center" colspan="1" rowspan="1" valign="top">OTU</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">97751</td>
<td align="center" colspan="1" rowspan="1" valign="top">82942</td>
<td align="center" colspan="1" rowspan="1" valign="top">452</td>
<td align="center" colspan="1" rowspan="1" valign="top">291</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A2</td>
<td align="center" colspan="1" rowspan="1" valign="top">147122</td>
<td align="center" colspan="1" rowspan="1" valign="top">132071</td>
<td align="center" colspan="1" rowspan="1" valign="top">452</td>
<td align="center" colspan="1" rowspan="1" valign="top">269</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A3</td>
<td align="center" colspan="1" rowspan="1" valign="top">104463</td>
<td align="center" colspan="1" rowspan="1" valign="top">88679</td>
<td align="center" colspan="1" rowspan="1" valign="top">457</td>
<td align="center" colspan="1" rowspan="1" valign="top">301</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A4</td>
<td align="center" colspan="1" rowspan="1" valign="top">109556</td>
<td align="center" colspan="1" rowspan="1" valign="top">94243</td>
<td align="center" colspan="1" rowspan="1" valign="top">457</td>
<td align="center" colspan="1" rowspan="1" valign="top">206</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A5</td>
<td align="center" colspan="1" rowspan="1" valign="top">92412</td>
<td align="center" colspan="1" rowspan="1" valign="top">80310</td>
<td align="center" colspan="1" rowspan="1" valign="top">457</td>
<td align="center" colspan="1" rowspan="1" valign="top">145</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A6</td>
<td align="center" colspan="1" rowspan="1" valign="top">100046</td>
<td align="center" colspan="1" rowspan="1" valign="top">85055</td>
<td align="center" colspan="1" rowspan="1" valign="top">461</td>
<td align="center" colspan="1" rowspan="1" valign="top">190</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">H1</td>
<td align="center" colspan="1" rowspan="1" valign="top">48699</td>
<td align="center" colspan="1" rowspan="1" valign="top">36373</td>
<td align="center" colspan="1" rowspan="1" valign="top">446</td>
<td align="center" colspan="1" rowspan="1" valign="top">239</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">H2</td>
<td align="center" colspan="1" rowspan="1" valign="top">46394</td>
<td align="center" colspan="1" rowspan="1" valign="top">36601</td>
<td align="center" colspan="1" rowspan="1" valign="top">449</td>
<td align="center" colspan="1" rowspan="1" valign="top">231</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">H3</td>
<td align="center" colspan="1" rowspan="1" valign="top">72834</td>
<td align="center" colspan="1" rowspan="1" valign="top">53787</td>
<td align="center" colspan="1" rowspan="1" valign="top">448</td>
<td align="center" colspan="1" rowspan="1" valign="top">218</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">H4</td>
<td align="center" colspan="1" rowspan="1" valign="top">84893</td>
<td align="center" colspan="1" rowspan="1" valign="top">61487</td>
<td align="center" colspan="1" rowspan="1" valign="top">447</td>
<td align="center" colspan="1" rowspan="1" valign="top">224</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">H5</td>
<td align="center" colspan="1" rowspan="1" valign="top">80500</td>
<td align="center" colspan="1" rowspan="1" valign="top">51148</td>
<td align="center" colspan="1" rowspan="1" valign="top">457</td>
<td align="center" colspan="1" rowspan="1" valign="top">226</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Average</td>
<td align="center" colspan="1" rowspan="1" valign="top">89515.45</td>
<td align="center" colspan="1" rowspan="1" valign="top">72972.36</td>
<td align="center" colspan="1" rowspan="1" valign="top">453</td>
<td align="center" colspan="1" rowspan="1" valign="top">230.91</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Shared Genera in Each Sample</title>
<p>The Venn figure could reflect the difference between group A and group H. As shown in <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, there were 386 and 279 OTUs in group A and H, and the percent of their common OUTs were 63.0% (243/386) and 87.1% (243/279), respectively. For group H, 43.78% OTUs (169/386) were identified as common OUTs among samples H1, H2, H3, H4, and H5, while the common OTUs only occupied 17.56% (49/279) among samples A1, A2, A3, A4, A5, and A6.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p><bold>Scalar–Venn representation of the microbiota between groups A and H. (A)</bold> Shared OUTs among samples H1, H2, H3, H4, and H5. <bold>(B)</bold> Shared OUTs among samples A1, A2, A3, A4, A5, and A6. <bold>(C)</bold> Shared OUTs between groups A and H.</p>
</caption>
<graphic xlink:href="fmicb-07-01479-g001"></graphic>
</fig>
</sec>
<sec>
<title>The β Diversity of the Microbial Community</title>
<p>The overall picture of the microbial composition of the samples in group A and H was obtained by PCoA, based on the relative abundance profiles of bacterial taxa. As shown in <bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>, 5/5 samples in group H clustered together on the right upper of the coordinate axis, and 5/6 samples in group A gathered together on the left upper of the coordinate axis, and samples in group H were obviously deviated from the samples in group A (<bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>), which was future confirmed by UPGMA method (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p><bold>The Principle component analysis (PCA) (A) and UPGMA Method of Beta diversity index (B) of groups A and H</bold>.</p>
</caption>
<graphic xlink:href="fmicb-07-01479-g002"></graphic>
</fig>
</sec>
<sec>
<title>Composition of the Bacterial Communities at Genus Level</title>
<p>At the genus level, data of top 10 microorganism populations was analyzed. As shown in <bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>, <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Anaerostipes</italic>, <italic>Prevotella</italic>, and <italic>Escherichia</italic> constituted five common dominant genus in group A and H (7.38 vs. 9.41%, 15.32 vs. 7.02%, 23.9 vs. 7.0%, 10.42 vs. 29.86%, 2.57 vs. 3.24%), which accounted for 59.59 and 56.53% of the total sequencing number, and the bacteria did not belong to the dominant bacteria in these two groups and classified as the “others” had occupied 30.77 and 38.29%. In addition, the average ratios of <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Anaerostipes</italic>, <italic>Prevotella</italic>, <italic>Escherichia</italic>, and <italic>Lachnospira</italic> between groups A and H were 0.78, 2.18, 3.41, 0.35, 0.79, and 13.07 (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p><bold>Composition and relative abundance of bacterial communities based 16S rDNA sequences in A and H groups. (A)</bold> Unsupervised hierarchical clustering analysis. <bold>(B)</bold> The relative abundances of the major bacteria in genus level.</p>
</caption>
<graphic xlink:href="fmicb-07-01479-g003"></graphic>
</fig>
</sec>
<sec>
<title>Relative Abundance of the Bacterial Communities in Each Sample</title>
<p>To determine the significant increased bacteria in group A or H, supervised comparisons by LEfSE (LDA &gt; 4.0) were performed. In <bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>, <italic>Lachnospiraceae</italic> (at family level), <italic>Firmicutes</italic> (at phylum level), <italic>Clostridia</italic> (at class level), <italic>Oscillibacter</italic> (at genus level), <italic>Family XIII</italic> (at family level), <italic>Anaerostipes</italic> (at genus level), <italic>Lachnospiraceae</italic> (at genus level) and <italic>Clostridiales</italic> (at order level) in group H were significant higher than that in group A, while <italic>Bacteroidetes</italic> (at phylum level), <italic>Bacteroidia</italic> (at class level), <italic>Bacteroidales</italic> (at order level), <italic>Dorea</italic> (at genus level) were significant higher than that in group H.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p><bold>Supervised comparison identifies differential abundance of bacteria using LEfSe (LDA &gt; 4.0)</bold>.</p>
</caption>
<graphic xlink:href="fmicb-07-01479-g004"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>Accumulating clinical- and scientific research-based evidence is driving our increased awareness of the significance of the human microbiome (HM) to the healthy and homeostatic operation of the human CNS (<xref ref-type="bibr" rid="B13">Grenham et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Hill et al., 2014</xref>; <xref ref-type="bibr" rid="B11">Fang, 2015</xref>; <xref ref-type="bibr" rid="B16">Kennedy et al., 2016</xref>). ALS belongs to neurodegenerative disease characterized by the loss of motor neurons (<xref ref-type="bibr" rid="B28">Scarrott et al., 2015</xref>), and the prevalence rate for ALS is substantially lower at 3.9/100000 in the United States (<xref ref-type="bibr" rid="B23">Mehta, 2015</xref>). To date, the pathogenesis of ALS remains unclear and is likely multifactorial, and the pathophysiology of ALS may be related to the gastrointestinal tract. The gut microbiota, which is also referred to as the second brain, may affect brain activity through the gut-microbiota–brain axis under both physiological and pathological conditions (<xref ref-type="bibr" rid="B21">Mayer et al., 2015</xref>; <xref ref-type="bibr" rid="B27">Sampson and Mazmanian, 2015</xref>), and accumulating evidence suggests that microbiota changes in the gastrointestinal tract of individuals possessed strong connection with neurological diseases and specifically, neurodegenerative diseases (<xref ref-type="bibr" rid="B7">Catanzaro et al., 2015</xref>).</p>
<p>In this study, high-throughput sequencing technology was used to compare the microbiota in intestinal tract of healthy people and ALS patients. To evaluate the tag quality, the raw tags, clean tags, average bp and OTUs in per sample were compared, and the mean number of 72972.36 clean tags, average length of 453 bp (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>), and the saturated Chao1 index and rarefaction curve ensured their reliability for the future analysis (Supplementary Figure S1).</p>
<p>In <bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, the Venn figure reflected a high percent of 43.78% of common OTUs in H group, and a low percent of 17.56% of common OTUs in A group, which indicated that the ALS, together with individual physiological status, had severely changed the microbial composition in patients feces, which deviating from the normal microbiota and characterized by the overgrowth of total OTU number and low percent of common OTUs. Moreover, the clustered samples A1, A2, A3, A4, and A6, as well as the clustered samples H1, H2, H3, H4, and H5 using PCoA and UPGMA method further conformed the microbial changes in feces of ALS patients (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>).</p>
<p>Then, the top 10 microorganism populations were analyzed at genus level, and average ratios of <italic>Bacteroides</italic>, <italic>Faecalibacterium</italic>, <italic>Anaerostipes</italic>, <italic>Prevotella</italic>, <italic>Escherichia</italic>, and <italic>Lachnospira</italic> between groups A and H were 0.78, 2.18, 3.41, 0.35, 0.79, and 13.07 (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>). Furthermore, supervised comparisons by LEfSE (LDA &gt; 4.0) were performed to find the significant changed bacteria, and the relative richness of <italic>Firmicutes</italic> at phylum level, <italic>Clostridia</italic> at class level, <italic>Clostridiales</italic> at order level, <italic>Lachnospiraceae</italic> and <italic>Family XIII</italic> at family level, <italic>Oscillibacter</italic>, <italic>Anaerostipes</italic> and <italic>Lachnospiraceae</italic> at genus level in group H were significant higher than that in group A, while <italic>Bacteroidetes</italic> at phylum level, <italic>Bacteroidia</italic> at class level, <italic>Bacteroidales</italic> at order level and <italic>Dorea</italic> at genus level were significant higher in group A (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>).</p>
<p>In healthy adults, 80% of the identified fecal microbes can be classified into three dominant phyla: <italic>Bacteroidetes, Firmicutes</italic>, and <italic>Actinobacteria</italic>, and the <italic>Firmicutes</italic> to <italic>Bacteroidetes</italic> ratio is regarded to be of significant relevance with human health (<xref ref-type="bibr" rid="B20">Mariat et al., 2009</xref>), and the significant increase of <italic>Firmicutes</italic> in H group and significant increase of <italic>Bacteroidetes</italic> in A group indicated that the ALS has seriously influenced patients’ healthy, characterized by the decreased <italic>Firmicutes/Bacteroidetes</italic> ratio. At genus level, the <italic>Dorea</italic> in group A was significant higher than that in healthy people, whose major end products of glucose metabolism are ethanol (<xref ref-type="bibr" rid="B33">Vos et al., 2011</xref>). Moreover, the significant decrease of <italic>Oscillibacter</italic> (was found in significantly more samples from healthy control test subjects than from patients diagnosed with Crohn’s disease; <xref ref-type="bibr" rid="B24">Mondot et al., 2011</xref>), <italic>Anaerostipes</italic> (represents more than 2% of total colonic microbiota in the healthy colon, and are believed to play an important functional role in the gut ecosystem due to their ability to produce butyrate from lactate; <xref ref-type="bibr" rid="B4">Bui et al., 2014</xref>) and <italic>Lachnospiraceae</italic> (can protect from colon cancer in humans by producing butyric acid; <xref ref-type="bibr" rid="B22">Meehan and Beiko, 2014</xref>) in group A further confirmed the interaction of ALS with intestinal microbiota.</p>
<p>In summary, we found that host microbiota were markedly different in health and disease, and the overgrowing of pathogens and reduction of probiotic organisms in intestines of ALS patients might up-regulated or down-regulated the production of NO, GABA, SCFAs, and LPS, which eventually increased the pathogenesis of ALS, and the ALS conversely aggravated the imbalances of intestinal microbiota, causing a vicious circle for host health. In the present study, we provide basic data to clarify the key bacteria during disease occurring, which may assist our understanding and treatment of ALS by inhibiting the growth of pathogens and enhancing the number of probiotics.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>TC designed the experiment; XF, XnW, SY, FM, and XaW performed the experiments; TC and HW analyzed the data and wrote the manuscript. All authors discussed the results and commented on the manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grants from the National Natural Science Foundation of China (No. 81503364, 31560264, and 21461015) and the Jiangxi Government (20142BAB205092, GJJ150250, 20151BAB205001, KJLD14010, and 20153BCB23035).</p>
</fn>
</fn-group>
<ack>
<p>The responsibility for the article content lies solely with the authors.</p>
</ack>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://metastats.cbcb.umd.edu/">http://metastats.cbcb.umd.edu/</ext-link>
</p>
</fn>
</fn-group>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2016.01479">http://journal.frontiersin.org/article/10.3389/fmicb.2016.01479</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Data_Sheet_1.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>J. B.</given-names></name><name><surname>Johansen</surname><given-names>L. J.</given-names></name><name><surname>Powell</surname><given-names>L. D.</given-names></name><name><surname>Quig</surname><given-names>D.</given-names></name><name><surname>Rubin</surname><given-names>R. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity.</article-title>
<source/><italic>BMC Gastroenterol.</italic>
<volume>11</volume>:<issue>22</issue>
<pub-id pub-id-type="doi">10.1186/1471-230X-11-22</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>This article corrects: gamma-Aminobutyric acid production by culturable bacteria from the human intestine.</article-title>
<source/><italic>J. Appl. Microbiol.</italic>
<volume>116</volume>
<fpage>1384</fpage>–<lpage>1386</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05344.x</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>B. R.</given-names></name><name><surname>Miller</surname><given-names>R. G.</given-names></name><name><surname>Swash</surname><given-names>M.</given-names></name><name><surname>Munsat</surname><given-names>T. L.</given-names></name></person-group> (<year>2000</year>). <article-title>El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Amyotroph. Lateral. Scler. Other Motor Neuron Disord.</italic>
<volume>1</volume>
<fpage>293</fpage>–<lpage>299</lpage>.<pub-id pub-id-type="pmid">11464847</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>T. P. N.</given-names></name><name><surname>de Vos</surname><given-names>W. M.</given-names></name><name><surname>Plugge</surname><given-names>C. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Anaerostipes rhamnosivorans sp. nov., a human intestinal, butyrate-forming bacterium.</article-title>
<source/><italic>Int. J. Syst. Bacteriol.</italic>
<volume>64</volume>
<fpage>787</fpage>–<lpage>793</lpage>. <pub-id pub-id-type="doi">10.1099/ijs.0.055061-0</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cani</surname><given-names>P. D.</given-names></name><name><surname>Knauf</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>How gut microbes talk to organs: the role of endocrine and nervous routes.</article-title>
<source/><italic>Mol. Metab.</italic>
<volume>5</volume>
<fpage>743</fpage>–<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2016.05.011</pub-id><pub-id pub-id-type="pmid">27617197</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>J. G.</given-names></name><name><surname>Kuczynski</surname><given-names>J.</given-names></name><name><surname>Stombaugh</surname><given-names>J.</given-names></name><name><surname>Bittinger</surname><given-names>K.</given-names></name><name><surname>Bushman</surname><given-names>F. D.</given-names></name><name><surname>Costello</surname><given-names>E. K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>QIIME allows analysis of high-throughput community sequencing data.</article-title>
<source/><italic>Nat. Methods</italic>
<volume>7</volume>
<fpage>335</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.f.303</pub-id><pub-id pub-id-type="pmid">20383131</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catanzaro</surname><given-names>R.</given-names></name><name><surname>Anzalone</surname><given-names>M.</given-names></name><name><surname>Calabrese</surname><given-names>F.</given-names></name><name><surname>Milazzo</surname><given-names>M.</given-names></name><name><surname>Capuana</surname><given-names>M.</given-names></name><name><surname>Italia</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The gut microbiota and its correlations with the central nervous system disorders.</article-title>
<source/><italic>Panminerva Med.</italic>
<volume>57</volume>
<fpage>127</fpage>–<lpage>143</lpage>.<pub-id pub-id-type="pmid">25390799</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davenport</surname><given-names>M.</given-names></name><name><surname>Poles</surname><given-names>J.</given-names></name><name><surname>Leung</surname><given-names>J. M.</given-names></name><name><surname>Wolff</surname><given-names>M. J.</given-names></name><name><surname>Abidi</surname><given-names>W. M.</given-names></name><name><surname>Ullman</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.</article-title>
<source/><italic>Inflamm. Bowel Dis.</italic>
<volume>20</volume>
<fpage>723</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000000011</pub-id><pub-id pub-id-type="pmid">24583479</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derrien</surname><given-names>M.</given-names></name><name><surname>van Hylckama Vlieg</surname><given-names>J. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Fate, activity, and impact of ingested bacteria within the human gut microbiota.</article-title>
<source/><italic>Trends Microbiol.</italic>
<volume>23</volume>
<fpage>354</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2015.03.002</pub-id><pub-id pub-id-type="pmid">25840765</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erny</surname><given-names>D.</given-names></name><name><surname>Hrabe de Angelis</surname><given-names>A. L.</given-names></name><name><surname>Jaitin</surname><given-names>D.</given-names></name><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Staszewski</surname><given-names>O.</given-names></name><name><surname>David</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Host microbiota constantly control maturation and function of microglia in the CNS.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>18</volume>
<fpage>965</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4030</pub-id><pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Potential role of gut microbiota and tissue barriers in Parkinson’s disease and amyotrophic lateral sclerosis.</article-title>
<source/><italic>Int. J. Neurosci.</italic>
<volume>126</volume>
<fpage>771</fpage>–<lpage>776</lpage>. <pub-id pub-id-type="doi">10.3109/00207454.2015.1096271</pub-id><pub-id pub-id-type="pmid">26381230</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>P. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.</article-title>
<source/><italic>CNS Drugs</italic>
<volume>25</volume>
<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.2165/11586000-000000000-00000</pub-id><pub-id pub-id-type="pmid">21128691</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenham</surname><given-names>S.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain-gut-microbe communication in health and disease.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>2</volume>:<issue>94</issue>
<pub-id pub-id-type="doi">10.3389/fphys.2011.00094</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>B. J.</given-names></name><name><surname>Gevers</surname><given-names>D.</given-names></name><name><surname>Earl</surname><given-names>A. M.</given-names></name><name><surname>Feldgarden</surname><given-names>M.</given-names></name><name><surname>Ward</surname><given-names>D. V.</given-names></name><name><surname>Giannoukos</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Chimeric 16S rRNA sequence formation and detection in sanger and 454-pyrosequenced PCR amplicons.</article-title>
<source/><italic>Genome Res.</italic>
<volume>21</volume>
<fpage>494</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.112730.110</pub-id><pub-id pub-id-type="pmid">21212162</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>J. M.</given-names></name><name><surname>Bhattacharjeeand</surname><given-names>S.</given-names></name><name><surname>Pogue</surname><given-names>A. I.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The gastrointestinal tract microbiome and potential link to Alzheimer’s Disease.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>5</volume>:<issue>43</issue>
<pub-id pub-id-type="doi">10.3389/fneur.2014.00043</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>P.</given-names></name><name><surname>Cryan</surname><given-names>J.</given-names></name><name><surname>Dinan</surname><given-names>T.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Kynurenine pathway metabolism and the microbiota-gut-brain axis.</article-title>
<source/><italic>Neuropharmacology.</italic>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.07.002</pub-id>
<comment>[Epub ahead of print]</comment>.</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiernan</surname><given-names>M. C.</given-names></name><name><surname>Vucic</surname><given-names>S.</given-names></name><name><surname>Cheah</surname><given-names>B. C.</given-names></name><name><surname>Turner</surname><given-names>M. R.</given-names></name><name><surname>Eisen</surname><given-names>A.</given-names></name><name><surname>Hardiman</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>Lancet</italic>
<volume>377</volume>
<fpage>942</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)61156-7</pub-id><pub-id pub-id-type="pmid">21296405</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longstreth</surname><given-names>W.</given-names></name><name><surname>Meschke</surname><given-names>J.</given-names></name><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>Smoot</surname><given-names>L.</given-names></name><name><surname>Smoot</surname><given-names>J.</given-names></name><name><surname>Koepsell</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS.</article-title>
<source/><italic>Med. Hypotheses</italic>
<volume>6</volume>
<fpage>1153</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2004.07.041</pub-id><pub-id pub-id-type="pmid">15823706</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>K.</given-names></name><name><surname>Ryan</surname><given-names>P. A.</given-names></name><name><surname>Schlieper</surname><given-names>K. A.</given-names></name><name><surname>Graffam</surname><given-names>M. E.</given-names></name><name><surname>Levine</surname><given-names>S.</given-names></name><name><surname>Wishnok</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis.</article-title>
<source/><italic>Environ. Health Perspect.</italic>
<volume>122</volume>
<issue>284</issue>
<pub-id pub-id-type="doi">10.1289/ehp.1307429</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariat</surname><given-names>D.</given-names></name><name><surname>Firmesse</surname><given-names>O.</given-names></name><name><surname>Levenez</surname><given-names>F.</given-names></name><name><surname>Guimarăes</surname><given-names>V.</given-names></name><name><surname>Sokol</surname><given-names>H.</given-names></name><name><surname>Dore</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>The firmicutes/bacteroidetes ratio of the human microbiota changes with age.</article-title>
<source/><italic>BMC Microbiol.</italic>
<volume>9</volume>:<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/1471-2180-9-123</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>E. A.</given-names></name><name><surname>Tillisch</surname><given-names>K.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Gut/brain axis and the microbiota.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>926</fpage>–<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1172/JCI76304</pub-id><pub-id pub-id-type="pmid">25689247</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meehan</surname><given-names>C. J.</given-names></name><name><surname>Beiko</surname><given-names>R. G.</given-names></name></person-group> (<year>2014</year>). <article-title>A phylogenomic view of ecological specialization in the lachnospiraceae, a family of digestive tract-associated bacteria.</article-title>
<source/><italic>Genome Biol. Evol.</italic>
<volume>6</volume>
<fpage>703</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1093/gbe/evu050</pub-id><pub-id pub-id-type="pmid">24625961</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence of amyotrophic lateral sclerosis-united states, 2010-2011.</article-title>
<source/><italic>Am. J. Public Health</italic>
<volume>105</volume>
<fpage>e7</fpage>–<lpage>e9</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2015.302747</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondot</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Furet</surname><given-names>J.-P.</given-names></name><name><surname>Aguirre de Cárcer</surname><given-names>D.</given-names></name><name><surname>McSweeney</surname><given-names>C.</given-names></name><name><surname>Morrison</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Highlighting new phylogenetic specificities of Crohn’s disease microbiota.</article-title>
<source/><italic>Inflamm. Bowel Dis.</italic>
<volume>17</volume>
<fpage>185</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21436</pub-id><pub-id pub-id-type="pmid">20722058</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>M. D.</given-names></name><name><surname>D’Aigle</surname><given-names>T.</given-names></name><name><surname>Gowing</surname><given-names>G.</given-names></name><name><surname>Julien</surname><given-names>J.-P.</given-names></name><name><surname>Rivest</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>24</volume>
<fpage>1340</fpage>–<lpage>1349</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4786-03.2004</pub-id><pub-id pub-id-type="pmid">14960605</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>S. H.</given-names></name><name><surname>Pothoulakis</surname><given-names>C.</given-names></name><name><surname>Mayer</surname><given-names>E. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Principles and clinical implications of the brain-gut-enteric microbiota axis.</article-title>
<source/><italic>Nat. Rev. Gastroenterol. Hepatol.</italic>
<volume>6</volume>
<fpage>306</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2009.35</pub-id><pub-id pub-id-type="pmid">19404271</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>T. R.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Control of brain development, function, and behavior by the microbiome.</article-title>
<source/><italic>Cell Host Microbe</italic>
<volume>17</volume>
<fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.04.011</pub-id><pub-id pub-id-type="pmid">25974299</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarrott</surname><given-names>J. M.</given-names></name><name><surname>Herranz-Martín</surname><given-names>S.</given-names></name><name><surname>Alrafiah</surname><given-names>A. R.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name><name><surname>Azzouz</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Current developments in gene therapy for amyotrophic lateral sclerosis.</article-title>
<source/><italic>Expert Opin. Biol. Ther.</italic>
<volume>15</volume>
<fpage>935</fpage>–<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1517/14712598.2015.1044894</pub-id><pub-id pub-id-type="pmid">25959569</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schloss</surname><given-names>P. D.</given-names></name><name><surname>Westcott</surname><given-names>S. L.</given-names></name><name><surname>Ryabin</surname><given-names>T.</given-names></name><name><surname>Hall</surname><given-names>J. R.</given-names></name><name><surname>Hartmann</surname><given-names>M.</given-names></name><name><surname>Hollister</surname><given-names>E. B.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>75</volume>
<fpage>7537</fpage>–<lpage>7541</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01541-09</pub-id><pub-id pub-id-type="pmid">19801464</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serre</surname><given-names>C. B. D. L.</given-names></name><name><surname>Lartigue</surname><given-names>G. D.</given-names></name><name><surname>Raybould</surname><given-names>H. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons.</article-title>
<source/><italic>Physiol. Behav.</italic>
<volume>139</volume>
<fpage>188</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2014.10.032</pub-id><pub-id pub-id-type="pmid">25446227</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shokralla</surname><given-names>S.</given-names></name><name><surname>Spall</surname><given-names>J. L.</given-names></name><name><surname>Gibson</surname><given-names>J. F.</given-names></name><name><surname>Hajibabaei</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Next-generation sequencing technologies for environmental DNA research.</article-title>
<source/><italic>Mol. Ecol.</italic>
<volume>21</volume>
<fpage>1794</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-294X.2012.05538.x</pub-id><pub-id pub-id-type="pmid">22486820</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivan</surname><given-names>A.</given-names></name><name><surname>Corrales</surname><given-names>L.</given-names></name><name><surname>Hubert</surname><given-names>N.</given-names></name><name><surname>Williams</surname><given-names>J. B.</given-names></name><name><surname>Aquino-Michaels</surname><given-names>K.</given-names></name><name><surname>Earley</surname><given-names>Z. M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Commensal bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy.</article-title>
<source/><italic>Science</italic>
<volume>350</volume>
<fpage>1084</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac4255</pub-id><pub-id pub-id-type="pmid">26541606</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vos</surname><given-names>P.</given-names></name><name><surname>Garrity</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>D.</given-names></name><name><surname>Krieg</surname><given-names>N. R.</given-names></name><name><surname>Ludwig</surname><given-names>W.</given-names></name><name><surname>Rainey</surname><given-names>F. A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <source/><italic>Bergey’s Manual of Systematic Bacteriology: The Firmicutes</italic>, <volume>Vol. 3.</volume>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer Science &amp; Business Media.</publisher-name></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>I.-S.</given-names></name><name><surname>Braun</surname><given-names>C.</given-names></name><name><surname>Enck</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Effect of probiotics on central nervous system functions in animals and humans–a systematic review.</article-title>
<source/><italic>J. Neurogastroenterol. Motil.</italic>
<pub-id pub-id-type="doi">10.5056/jnm16018</pub-id>
<comment>[Epub ahead of print]</comment>.</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>B.</given-names></name><name><surname>Vanbenschoten</surname><given-names>A.</given-names></name><name><surname>Cimermancic</surname><given-names>P.</given-names></name><name><surname>Donia</surname><given-names>M.</given-names></name><name><surname>Zimmermann</surname><given-names>M.</given-names></name><name><surname>Mao</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine.</article-title>
<source/><italic>Cell Host Microbe</italic>
<volume>16</volume>
<fpage>495</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2014.09.001</pub-id><pub-id pub-id-type="pmid">25263219</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Lian</surname><given-names>F. M.</given-names></name><name><surname>Zhao</surname><given-names>L. H.</given-names></name><name><surname>Zhao</surname><given-names>Y. F.</given-names></name><name><surname>Chen</surname><given-names>X. Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula.</article-title>
<source/><italic>Isme. J.</italic>
<volume>9</volume>
<fpage>552</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1038/ismej.2014</pub-id><pub-id pub-id-type="pmid">25279787</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Qiu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Gan</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Analysis of the intestinal microbial community structure of healthy and long-living elderly residents in gaotian village of Liuyang City.</article-title>
<source/><italic>Appl. Microbiol. Biotechnol.</italic>
<volume>99</volume>
<fpage>9085</fpage>–<lpage>9095</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-015-6888-3</pub-id><pub-id pub-id-type="pmid">26298698</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue-Xin</surname><given-names>M.</given-names></name><name><surname>Holmstrom</surname><given-names>C.</given-names></name><name><surname>Webb</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Application of denaturing gradient gel electrophoresis (DGGE) in microbial ecology.</article-title>
<source/><italic>Acta Ecol. Sin.</italic>
<volume>8</volume>
<issue>014</issue>.</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Miller</surname><given-names>R. G.</given-names></name><name><surname>Gascon</surname><given-names>R.</given-names></name><name><surname>Champion</surname><given-names>S.</given-names></name><name><surname>Katz</surname><given-names>J.</given-names></name><name><surname>Lancero</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>206</volume>
<fpage>121</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.09.017</pub-id><pub-id pub-id-type="pmid">19013651</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhernakova</surname><given-names>A.</given-names></name><name><surname>Kurilshikov</surname><given-names>A.</given-names></name><name><surname>Bonder</surname><given-names>M. J.</given-names></name><name><surname>Tigchelaar</surname><given-names>E. F.</given-names></name><name><surname>Schirmer</surname><given-names>M.</given-names></name><name><surname>Vatanen</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>
<fpage>565</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3369</pub-id><pub-id pub-id-type="pmid">27126040</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>